Business expansion
Ostösterreich; Wien;
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

500 jobs
Number of planned job creations
Job creation
Announcement Date
6 April 2017
Employment effect (start)
6 April 2017
Foreseen end date
31 December 2021


The German manufacturer of pharmaceutical products Boehringer Ingelheim has announced plans to expand its production site in Vienna creating up to 500 new jobs.

Boehringer is investing €700 million in a new cell culture plant in Vienna (in the district of Meidling) which will produce biopharmaceutical drugs to meet the needs of a growing market. The new plant will go into operation in 2021. However, new employees for the planning and construction of the new site have already been hired. The company is looking for high qualified staff, including process engineers, pharmacists, laboratory technicians but also people working in sales and distribution.

Currently, Boehringer employs 1,630 people in Vienna. 

Update 11/10/2021: The facility has been opened and all the staff has been hired. 


  • 6 April 2017: orf online
  • 6 April 2017: Die Presse
  • 6 April 2017: Der Standard


Eurofound (2017), Boehringer Ingelheim, Business expansion in Austria, factsheet number 90686, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/90686.